Technology Alliances

Our Alliances in Research & Development

Complementing our in-house research & development efforts, our partnering activities focus on our strategic therapeutic areas. In our constant quest for "Value through Innovation", we are engaged in successful ongoing partnerships and are actively seeking new collaborations with external partners ranging from academic institutions to start-up companies or biotechnological enterprises. Strong alliance management functions at Boehringer Ingelheim ensure high-level commitment to successful execution of partnerships.

Extract of ongoing Alliances

Antibody technologies Antitope Ltd.
Medarex, Inc.
MorphoSys AG
Xencor, Inc.
Biomarker Caprion Proteomics, Inc.
Rules-Based Medicine, Inc.
Devices Vectura Group plc
Disease related drug discovery Axxam SpA
Evotec AG
Fragment based screening Graffinity Pharmaceuticals GmbH
High throughput screening Astex Therapeutics Ltd.
Evotec AG
Integrated electronic data handling Biomax Informatics AG
Genomatix Software GmbH
Medicinal chemistry Astex Therapeutics Ltd.
Evotec AG
Dalton Pharma Services
Protein formulation development XstalBio Ltd.
Protein crystallography Proteros biostructures GmbH
Protein scaffold technologies Ablynx nv
NascaCell Technologies AG
RNAi-related target discovery Cenix BioScience GmbH
Second generation biologics Syntonix Pharmaceuticals, Inc.
Target validation
and compound profiling
Asterand plc
Kinaxo Biotechnologies GmbH
Therapeutic proteins AbGenomics, Corp.
Evec, Inc.